Related Experiment Video

Updated: Aug 21, 2026

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
06:40

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

The cardiac beta2-adrenergic signalling a new role for the cPLA2

Catherine Pavoine1, Nicole Defer

  • 1Unité INSERM 581, Hôpital Henri Mondor, 94010 Creteil, France. pavoine@im3.inserm.fr

Cellular Signalling
|October 21, 2004
PubMed

Insights

Cardiac catecholamine actions involve beta(1)-adrenergic receptors (ARs) and increasingly recognized beta(2)-ARs. This review highlights the beta(2)-AR/Gi pathway, specifically cPLA(2), in heart function.

Area of Science:

  • Cardiovascular Physiology
  • Adrenergic Receptor Signaling
  • Molecular Cardiology

Background:

  • Cardiac catecholamine effects were traditionally linked to beta(1)-adrenergic receptors (ARs) via the Gs/AC/cAMP pathway.
  • Emerging evidence shows significant roles for cardiac beta(2)-ARs in healthy, aging, and failing hearts.
  • Beta(2)-ARs utilize atypical cAMP pathways and Gi-coupled lipidic pathways, with variations across species and conditions.

Purpose of the Study:

  • To review the functional significance of cardiac beta(2)-adrenergic receptors (ARs).
  • To focus on the less understood beta(2)-AR/Gi-coupled pathways.
  • Specifically, to examine the role of the cPLA(2) pathway linked to beta(2)-ARs.

Main Methods:

  • Literature review of existing studies on beta(2)-AR signaling in the heart.
  • Analysis of research on beta(2)-AR coupling to Gi proteins and downstream effectors.
  • Focus on studies investigating the cPLA(2) pathway in cardiac beta(2)-AR signaling.

Main Results:

  • Cardiac beta(2)-ARs are functionally relevant, particularly in pathological states like heart failure and aging.
  • Beta(2)-ARs engage complex signaling networks beyond the classical Gs/AC/cAMP pathway.
  • The beta(2)-AR/Gi-coupled cPLA(2) pathway represents a key, yet understudied, signaling axis.

Conclusions:

  • Cardiac beta(2)-ARs are crucial players in cardiovascular physiology and pathophysiology.
  • Understanding beta(2)-AR/Gi pathways, including cPLA(2), is vital for novel therapeutic strategies.
  • Further research into species- and condition-specific variations in beta(2)-AR signaling is warranted.

More Related Videos

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ06:03

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

Published on: March 22, 2024

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...